NIBR-0213 is a potent, competitive, and selective S1P1 receptor antagonist, demonstrating IC50 values of 2.0 nM (human) and 2.3 nM (rat) in GTPgammaS binding assays. It shows efficacy in the experimental autoimmune encephalomyelitis (EAE) model, supporting its use in researching multiple sclerosis and other autoimmune disorders.
Molekulargewicht:
464.98
Reinheit:
99.34% (May vary between batches)
CAS Nummer:
[1233332-14-3]
Formel:
C27H29ClN2O3
Target-Kategorie:
LPL Receptor
Anwendungsbeschreibung:
Solubility: DMSO:55 mg/mL (118.28 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten